1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 760 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

sales@MedChemExpress.cn

Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 760 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).

•   Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 760 kinase inhibitors/regulators supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Kinase Inhibitor Library

Source: MedChem Express

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Jujuboside A 3-Methyladenine 5-Aminosalicylic acid 2-Deoxy-D-glucose Metformin (hydrochloride) 3-Bromopyruvic acid Poloxime AG 18 Scopoletin MNS Empty
b Empty 4μ8C Trapidil AG126 CID755673 SP600125 RIPA-56 TDZD-8 SC-514 Resveratrol NSC95682 Empty
c Empty SU5416 Danthron SU9516 Phenformin (hydrochloride) CGP 57380 Piceatannol IQ-1S (free acid) NU2058 Y-27632 TG003 Empty
d Empty PHA-767491 (hydrochloride) kb NB 142-70 TPI-1 Chrysophanol BMS-345541 (free base) Bakuchiol AS-605240 AICAR Necrostatin-1 SMI-16a Empty
e Empty Anisomycin RG13022 Honokiol PD98059 Formononetin Apigenin Emodin Genistein SAR245409 Butein Empty
f Empty LY-364947 Bikinin TCS-PIM-1-4a RG14620 GW 441756 TC-DAPK 6 SC66 Indirubin-3'-monoxime TPCA-1 NU 7026 Empty
g Empty Compound 401 PP1 BX517 Tyrphostin A9 Y15 Wogonin Dihydroartemisinin Scutellarein A 77-01 RepSox Empty
h Empty Zoledronic acid (monohydrate) BMS-345541 CHR-6494 IRAK inhibitor 1 AG-490 [6]-Gingerol SU 5402 PF-06260933 JANEX-1 Poloxin Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SKF-86002 ID-8 Amlexanox Hispidulin Salidroside Nocodazole PP2 Quercetin SKI II MCB-613 Empty
b Empty AG1024 AS-252424 NSC23005 (sodium) PF-06447475 IRAK inhibitor 2 Ruxolitinib LY294002 Hydroxyfasudil Fingolimod AR-A014418 Empty
c Empty PP 242 LY3177833 INK-128 TSU-68 IC261 Thiazovivin AT13148 STO-609 AG-1478 Isorhamnetin Empty
d Empty Tyrphostin AG 879 LH846 STF-083010 1-Naphthyl PP1 TWS119 PP121 Vps34-PIK-III Dihydromyricetin Y-27632 (dihydrochloride) Triciribine Empty
e Empty SKLB1002 Lonidamine AG 555 PS-1145 Bupivacaine (hydrochloride) XL413 (hydrochloride) RKI-1447 Peficitinib Kenpaullone FR 180204 Empty
f Empty Fasudil (Hydrochloride) PD158780 TTP 22 SB 202190 1-NM-PP1 APY29 KW-2449 TCS JNK 5a Oglufanide GSK1059615 Empty
g Empty ZM 306416 GDC-0879 Tideglusib SL327 ML167 SB-505124 Dicoumarol DPH CC-115 AT7867 Empty
h Empty LM22A-4 Pim1/AKK1-IN-1 NVP-BVU972 PRT-060318 MSC2530818 PF-06409577 PQ401 CCT128930 SB 525334 Fingolimod (hydrochloride) Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty ETC-1002 BMS-265246 SSR128129E TG100-115 NG 52 L-779450 PI-103 Ingenol AZD-1480 CP-466722 Empty
b Empty SRPIN340 CX-4945 IPA-3 TA-01 Ro-3306 K02288 ML347 SD-208 1-Naphthyl PP1 (hydrochloride) VS-5584 Empty
c Empty Roscovitine TPX-0005 ISCK03 Coptisine (chloride) CGP60474 BIO WP1066 AICAR (phosphate) CH5183284 R1530 Empty
d Empty TAS-301 SAR131675 SGX-523 SB 415286 LFM-A13 PD153035 PD 169316 A-769662 TCS 359 PF06650833 Empty
e Empty PHA-793887 ZLN024 (hydrochloride) AZD-7762 MLN1117 R-268712 BML-277 CDK-IN-2 EMD638683 CZC24832 TGX-221 Empty
f Empty SC79 GSK180736A GW2580 MLN120B TCS PIM-1 1 APTO-253 Sanguinarine (chloride) ZM39923 (hydrochloride) LJI308 SB 239063 Empty
g Empty VE-821 PD168393 Tivantinib LY2157299 Brivanib MSDC 0160 LDC000067 SB 216763 Baricitinib AIM-100 Empty
h Empty SU6656 AZD-5438 CX-4945 (sodium salt) PF-04217903 Tetrahydrocurcumin SB1317 TEPP-46 CC-115 (hydrochloride) Src Inhibitor 1 Motesanib Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty GNF-2 CRT0066101 dihydrochloride Linifanib ENMD-2076 WHI-P154 JNJ-38877605 IM-12 CH5132799 SB 203580 HG-10-102-01 Empty
b Empty Ro 28-1675 CCT245737 BI-78D3 MLi-2 AZD1208 PF-4989216 DMH-1 ZINC00881524 SNS-032 TAK-659 (hydrochloride) Empty
c Empty CL-387785 LJH685 AT9283 PLX647 GDC-0326 GSK 650394 EAI045 Losmapimod GSK'872 IMD-0354 Empty
d Empty Chelerythrine Chloride WP1130 SB-431542 PI-103 (Hydrochloride) SNS-062 K145 (hydrochloride) AMG319 Acumapimod TIC10 TIC10 isomer Empty
e Empty MHY1485 APS-2-79 BIBX 1382 Purvalanol A T56-LIMKi ZM 336372 Solcitinib PIK-93 PF-4708671 BI-D1870 Empty
f Empty 5-Iodotubercidin Latrepirdine (dihydrochloride) Dovitinib Fruquintinib Erlotinib Reversine A66 IRAK-1-4 Inhibitor I KU-55933 Tanshinone IIA sulfonate (sodium) Empty
g Empty PD-166866 Toceranib IRAK inhibitor 6 Dinaciclib CID 2011756 IC-87114 CC-223 D4476 GSK583 Sunitinib Empty
h Empty BLZ945 GSK2578215A EW-7197 HLM006474 TAK-715 CVT-313 ACHP (Hydrochloride) Acalisib Flavopiridol Dehydrocorydaline (chloride) Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty VX-702 Ruxolitinib (phosphate) SGI-1776 PF-06463922 Palomid 529 OSI-027 LY3023414 LDN-212854 ANA-12 SR-3677 Empty
b Empty AZD 6482 PHT-427 Telatinib PF-670462 NVP-BKM120 AT7867 (dihydrochloride) PQR309 GS-9973 ZM323881 (hydrochloride) NT157 Empty
c Empty INCB28060 BIX02188 AZ20 AZD6738 APY0201 KU-57788 PLX-4720 SB 203580 (hydrochloride) AXL1717 CYT387 Empty
d Empty LTURM34 GNE-317 GSK2256098 SKLB610 CAL-101 ITD-1 Tomatidine GSK2656157 KRN-633 JH-II-127 Empty
e Empty Duvelisib (R enantiomer) Duvelisib ZSTK474 CP-673451 Pexidartinib GNF-5 TP-3654 AT7519 (Hydrochloride) LDN-214117 Vatalanib (dihydrochloride) Empty
f Empty CHIR-124 Linsitinib URMC-099 HS-173 CHZ868 AVL-292 AM-2394 NVP-BAW2881 HMN-214 LY3009120 Empty
g Empty CC-401 (hydrochloride) PF-04691502 GW788388 GSK-690693 GLPG0634 Vps34-IN-1 U0126 Lenvatinib Afuresertib Icotinib (Hydrochloride) Empty
h Empty Wortmannin LOXO-101 AZD5363 GSK2141795 BMS-3 ON123300 AZ191 Erlotinib (Hydrochloride) PRT062607 (Hydrochloride) AS703026 Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BMS-5 MK-8745 GSK429286A Torin 2 LDC4297 BMS-911543 Purvalanol B VRT752271 GSK2636771 CUDC-101 Empty
b Empty LEE011 TBB VX-745 LY2603618 Pazopanib XL228 Flavopiridol (Hydrochloride) Sotrastaurin S49076 PCI-32765 Empty
c Empty BIX02189 UNC2250 AEE788 MEK162 Brivanib (alaninate) BYL-719 LY2109761 SU14813 Go 6983 AZM475271 Empty
d Empty GNE-7915 OSI-930 Crenolanib LY2874455 SAR-20347 Cerdulatinib PF-04979064 Erdafitinib NVP-BKM120 (Hydrochloride) Gefitinib Empty
e Empty AZD2932 Amuvatinib Quercitrin PI3K inhibitor X AZD-3463 Crizotinib Cediranib ISRIB (trans-isomer) GSK2606414 AZ 628 Empty
f Empty SUN11602 SLx-2119 GDC-0349 AZ3146 Oclacitinib (maleate) AZD2858 SB-590885 ONO-4059 Tivozanib WHI-P97 Empty
g Empty SGI-7079 GDC-0623 BRAF inhibitor ONO-4059 (analog) AZD8186 AS 602801 Selumetinib GDC-0068 AZD3759 NVP-LCQ195 Empty
h Empty GDC-0032 PHA-848125 AZD8330 Necrosulfonamide BMS-754807 AZD0156 Perifosine MK-5108 CX-6258 Scutellarin Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty AZD2014 CEP-33779 GSK2334470 BAY 61-3606 (dihydrochloride) AMG-337 VE-822 AZD4547 UNC2881 Afuresertib (hydrochloride) BI-847325 Empty
b Empty Tozasertib MRT67307 Sorafenib CHIR-99021 Acalabrutinib KU-0063794 AZD-8055 JI-101 YM-201636 Pelitinib Empty
c Empty Mubritinib PF-04217903 (methanesulfonate) HTH-01-015 BMS-794833 NVP-TAE 226 Baricitinib (phosphate) Ki8751 CP-724714 AZD-8835 Dacomitinib Empty
d Empty LY2784544 R406 (free base) ETP-46464 MRT68921 (hydrochloride) BX-912 Ro 5126766 Dorsomorphin (dihydrochloride) Rigosertib (sodium) Sapitinib Pazopanib (Hydrochloride) Empty
e Empty PF-03814735 XMD8-92 Danusertib Vandetanib UNC2025 DMAT MLN8054 GW843682X CI-1040 AZD7545 Empty
f Empty B-Raf inhibitor 1 CCT241533 (hydrochloride) SBE13 (Hydrochloride) NVS-PAK1-1 BMS-536924 MK 2206 (dihydrochloride) Irbinitinib Mps1-IN-2 PD0325901 Dovitinib (lactate) Empty
g Empty CH5424802 Regorafenib IKK 16 Palbociclib (hydrochloride) Uridine triphosphate LY2409881 AZ-5104 Afatinib CHIR-98014 Olmutinib Empty
h Empty Crizotinib (hydrochloride) Dasatinib Bucladesine (calcium salt) CZC-25146 PIK-75 DCC-2618 PIK-294 Vemurafenib PF-3758309 ONO-4059 (hydrochloride) Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Poziotinib Bucladesine (sodium salt) PF-573228 EMD-1214063 Apatinib Imatinib Toceranib (phosphate) WZ4002 WYE-354 AT7519 (trifluoroacetate) Empty
b Empty WZ4003 CCT129202 GDC-0980 Masitinib CNX-774 CDK9-IN-1 AZD-9291 VX-11e MK-1775 Regorafenib (monohydrate) Empty
c Empty PND-1186 Cabozantinib PHA-680632 NVP-BHG712 AMG 900 TAK-733 Tofacitinib (citrate) TAK-901 CZC-54252 GSK2126458 Empty
d Empty MLN 2480 PI-3065 PF-562271 AZD1152-HQPA JNK-IN-8 GSK-1070916 BLU9931 TG101209 Defactinib LY2090314 Empty
e Empty BMS 777607 SCIO-469 UNC2025 (hydrochloride) FRAX486 CCT196969 ZM-447439 GDC-0941 Enzastaurin TP-0903 PDK1 inhibitor Empty
f Empty Hesperadin CEP-32496 MGCD-265 analog ALK inhibitor 2 RAF265 Alisertib CH5424802 (Hydrochloride) Regorafenib (Hydrochloride) H-89 (dihydrochloride) Dabrafenib Empty
g Empty WYE-125132 GW 5074 BI 2536 Tauroursodeoxycholate (Sodium) PD173074 Dasatinib (hydrochloride) TG-101348 LOXO-101 (sulfate) SNS-314 KX2-391 (Mesylate) Empty
h Empty Doramapimod IPI549 ALK-IN-1 Nilotinib AST 487 Lck Inhibitor GDC-0068 (dihydrochloride) Cobimetinib NMS-1286937 GZD824 Empty

Plate layout: HY-L009-9

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Ponatinib GSK1838705A CFI-400945 (free base) GNF-5837 Mps1-IN-1 BIBF 1120 XL-147 Saracatinib PLX8394 GSK461364 Empty
b Empty CNX-2006 Defactinib (hydrochloride) GNF-7 KU-60019 TAK-285 Pluripotin CCT 137690 AKT inhibitor VIII LDN193189 (Hydrochloride) LY2801653 Empty
c Empty DDR1-IN-1 LEE011 (succinate) DCC-2036 Ro 31-8220 (mesylate) TAK-632 CO-1686 CGK733 Neratinib LDK378 SU14813 (maleate) Empty
d Empty Canertinib (dihydrochloride) NVP-BGJ398 LDC1267 Entrectinib Quizartinib PD318088 BAY1217389 TAK-960 Flumatinib Tandutinib Empty
e Empty NVP-BSK805 (dihydrochloride) THZ1 Cediranib (maleate) BMS-599626 (Hydrochloride) SU11274 WH-4-023 Motesanib (Diphosphate) GSK269962A LEE011 (succinate hydrate) LRRK2-IN-1 Empty
f Empty TGR-1202 Refametinib Palbociclib (isethionate) CHIR-99021 (trihydrochloride) Bafetinib Belizatinib CGI-1746 CEP-37440 ASP3026 Lapatinib Empty
g Empty Nilotinib (monohydrochloride monohydrate) Brigatinib Aurora A inhibitor I Imatinib (Mesylate) BX795 A 419259 (trihydrochloride) Masitinib (mesylate) AZD-9291 (mesylate) PI3K-IN-1 THZ1 (Hydrochloride) Empty
h Empty LY2835219 Avitinib (maleate) Torin 1 KRCA-0008 CYT387 (sulfate salt) EG00229 Neohesperidin dihydrochalcone LY2228820 NVP-TAE 684 Trametinib Empty

Plate layout: HY-L009-10

1 2 3 4 5 6 7 8 9 10 11 12
a Empty GNE-7915 (tosylate) Dabrafenib (Mesylate) LY-2584702 (tosylate salt) Volasertib LYN-1604 hydrochloride Ginsenoside Rh2 R788(prodrug of R406) Verbascoside R406 Sitravatinib Empty
b Empty LDK378 (dihydrochloride) Centrinone-B Foretinib Centrinone TAK-960 (dihydrochloride) FIIN-2 CEP-28122 (mesylate salt) Cabozantinib (S-malate) CO-1686 (hydrobromide) Sorafenib (Tosylate) Empty
c Empty XMD17-109 PHA-665752 BEZ235 (Tosylate) Cobimetinib (hemifumarate) BIBF 1120 (esylate) NVP-BGT226 CFI-400945 (fumarate) Flumatinib (mesylate) GDC-0853 PF-562271 (besylate) Empty
d Empty Icariin Trametinib (DMSO solvate) SCR-1481B1 GDC-0941 (dimethanesulfonate) Afatinib (dimaleate) KN-62 R788 (disodium hexahydrate) Astragaloside IV GSK1904529A Lapatinib (ditosylate) Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
View More Collapse
Documentation

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

   电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Kinase Inhibitor Library
目录号:
HY-L009
需求量:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.